| Sarcoidosis |
1 |
1 |
| Clinical Research |
0 |
0.99 |
| Skin Lesion |
0 |
0.61 |
| Healthcare and Medical Technology |
0 |
0.28 |
| Biopsy |
0 |
0.12 |
| Drug Withdrawal |
0 |
0.12 |
| Eczema |
0 |
0.12 |
| Glucocorticoid |
0 |
0.12 |
| Grant |
0 |
0.12 |
| Heart |
0 |
0.12 |
| Hospital |
0 |
0.12 |
| Hyperglycemia |
0 |
0.12 |
| Hypertriglyceridemia |
0 |
0.12 |
| Lung |
0 |
0.12 |
| Molecular Medicine |
0 |
0.12 |
| mTOR Inhibitor |
0 |
0.12 |
| New York |
0 |
0.12 |
| Pathogenesis |
0 |
0.12 |
| Proteinuria |
0 |
0.12 |
| Rare Diseases |
0 |
0.12 |
| Refractory |
0 |
0.12 |
| Tumor |
0 |
0.12 |
| Cardiovascular Risk Management |
0 |
0.11 |
| Acne |
0 |
0.06 |
| Addiction |
0 |
0.06 |
| Dermatitis |
0 |
0.06 |
| Lipids Management |
0 |
0.06 |
| Skin and Soft Tissue Infection |
0 |
0.06 |